Structure

Physi-Chem Properties

Molecular Weight:  1812.78
Volume:  1686.494
LogP:  0.668
LogD:  0.675
LogS:  -2.158
# Rotatable Bonds:  25
TPSA:  676.57
# H-Bond Aceptor:  43
# H-Bond Donor:  24
# Rings:  14
# Heavy Atoms:  43

MedChem Properties

QED Drug-Likeness Score:  0.027
Synthetic Accessibility Score:  7.956
Fsp3:  0.88
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.72
MDCK Permeability:  0.0019765421748161316
Pgp-inhibitor:  0.0
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  1.0
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.387
Plasma Protein Binding (PPB):  48.18567657470703%
Volume Distribution (VD):  -0.609
Pgp-substrate:  15.899491310119629%

ADMET: Metabolism

CYP1A2-inhibitor:  0.0
CYP1A2-substrate:  0.002
CYP2C19-inhibitor:  0.0
CYP2C19-substrate:  0.045
CYP2C9-inhibitor:  0.0
CYP2C9-substrate:  0.001
CYP2D6-inhibitor:  0.0
CYP2D6-substrate:  0.022
CYP3A4-inhibitor:  0.004
CYP3A4-substrate:  0.0

ADMET: Excretion

Clearance (CL):  -1.833
Half-life (T1/2):  0.808

ADMET: Toxicity

hERG Blockers:  0.184
Human Hepatotoxicity (H-HT):  0.049
Drug-inuced Liver Injury (DILI):  0.066
AMES Toxicity:  0.034
Rat Oral Acute Toxicity:  0.036
Maximum Recommended Daily Dose:  0.051
Skin Sensitization:  0.296
Carcinogencity:  0.009
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.022

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC13989

Natural Product ID:  NPC13989
Common Name*:   Adianthifolioside B
IUPAC Name:   [(2S,3R,4S,5S,6R)-3-[(2S,3R,4S,5S,6S)-5-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-6-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] (3S,4aR,5R,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-3-(2-hydroxybenzoyl)oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
Synonyms:   Adianthifolioside B
Standard InCHIKey:  LSDHKFVHNGZFOG-GWCHSLTQSA-N
Standard InCHI:  InChI=1S/C83H128O43/c1-29-46(91)55(100)65(123-69-58(103)47(92)35(89)27-110-69)74(112-29)111-28-40-52(97)57(102)66(124-72-61(106)54(99)49(94)37(24-85)115-72)75(118-40)120-44-17-18-80(7)41(79(44,5)6)16-19-81(8)42(80)15-14-32-33-20-78(3,4)45(119-68(108)31-12-10-11-13-34(31)88)22-83(33,43(90)21-82(32,81)9)77(109)126-76-67(56(101)50(95)38(25-86)117-76)125-73-62(107)64(122-71-60(105)53(98)48(93)36(23-84)114-71)63(30(2)113-73)121-70-59(104)51(96)39(26-87)116-70/h10-14,29-30,33,35-67,69-76,84-107H,15-28H2,1-9H3/t29-,30+,33+,35-,36-,37-,38-,39+,40-,41+,42-,43-,44+,45+,46+,47+,48-,49-,50-,51+,52-,53+,54+,55+,56+,57+,58-,59-,60-,61-,62-,63+,64+,65-,66-,67-,69+,70+,71+,72+,73+,74-,75+,76+,80+,81-,82-,83-/m1/s1
SMILES:  OC[C@H]1O[C@@H](OC(=O)[C@@]23C[C@H](OC(=O)c4ccccc4O)C(C[C@H]3C3=CC[C@H]4[C@@]([C@@]3(C[C@H]2O)C)(C)CC[C@@H]2[C@]4(C)CC[C@@H](C2(C)C)O[C@@H]2O[C@H](CO[C@@H]3O[C@H](C)[C@@H]([C@@H]([C@H]3O[C@@H]3OC[C@H]([C@@H]([C@H]3O)O)O)O)O)[C@H]([C@@H]([C@H]2O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)O)O)(C)C)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O)O[C@@H]1O[C@H]([C@@H]([C@H]1O)O)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL507216
PubChem CID:   21629543
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001580] Triterpene glycosides
            • [CHEMONTID:0002358] Triterpene saponins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7559 Albizia adianthifolia Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[12662095]
NPO7559 Albizia adianthifolia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT15 Cell Line Jurkat Homo sapiens Activity = 1.21 n.a. PMID[499340]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC13989 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8735 High Similarity NPC329960
0.8735 High Similarity NPC150893
0.8735 High Similarity NPC295408
0.8713 High Similarity NPC469778
0.8713 High Similarity NPC469774
0.8713 High Similarity NPC100925
0.8713 High Similarity NPC295941
0.8713 High Similarity NPC32723
0.8713 High Similarity NPC469777
0.8713 High Similarity NPC135334
0.8713 High Similarity NPC469773
0.8713 High Similarity NPC469775
0.8713 High Similarity NPC469776
0.8713 High Similarity NPC469772
0.8698 High Similarity NPC477466
0.8698 High Similarity NPC477473
0.8698 High Similarity NPC477471
0.8698 High Similarity NPC477469
0.8698 High Similarity NPC469419
0.8671 High Similarity NPC176246
0.8663 High Similarity NPC124828
0.8605 High Similarity NPC477617
0.8571 High Similarity NPC72783
0.8571 High Similarity NPC477627
0.8563 High Similarity NPC170018
0.8563 High Similarity NPC76112
0.8563 High Similarity NPC66820
0.8563 High Similarity NPC92403
0.8555 High Similarity NPC65118
0.8529 High Similarity NPC478026
0.8528 High Similarity NPC116292
0.8528 High Similarity NPC87630
0.8528 High Similarity NPC179128
0.8528 High Similarity NPC162569
0.8528 High Similarity NPC35160
0.8528 High Similarity NPC267469
0.8521 High Similarity NPC187934
0.8521 High Similarity NPC97637
0.8506 High Similarity NPC223735
0.8506 High Similarity NPC307754
0.85 High Similarity NPC40085
0.85 High Similarity NPC264270
0.8497 Intermediate Similarity NPC183441
0.8488 Intermediate Similarity NPC471870
0.8466 Intermediate Similarity NPC187441
0.8466 Intermediate Similarity NPC283980
0.8453 Intermediate Similarity NPC475299
0.8452 Intermediate Similarity NPC53139
0.8452 Intermediate Similarity NPC314795
0.8448 Intermediate Similarity NPC471871
0.8438 Intermediate Similarity NPC111466
0.8421 Intermediate Similarity NPC478020
0.8421 Intermediate Similarity NPC102465
0.8421 Intermediate Similarity NPC478022
0.8418 Intermediate Similarity NPC197357
0.8418 Intermediate Similarity NPC85316
0.8409 Intermediate Similarity NPC469418
0.8395 Intermediate Similarity NPC320734
0.8389 Intermediate Similarity NPC475121
0.8389 Intermediate Similarity NPC476067
0.8383 Intermediate Similarity NPC476784
0.8383 Intermediate Similarity NPC472807
0.8372 Intermediate Similarity NPC149002
0.8372 Intermediate Similarity NPC469458
0.8372 Intermediate Similarity NPC88176
0.8372 Intermediate Similarity NPC469396
0.8372 Intermediate Similarity NPC469459
0.8363 Intermediate Similarity NPC475531
0.8363 Intermediate Similarity NPC475198
0.8363 Intermediate Similarity NPC475175
0.8353 Intermediate Similarity NPC69868
0.8352 Intermediate Similarity NPC475613
0.8352 Intermediate Similarity NPC198893
0.8352 Intermediate Similarity NPC314489
0.8352 Intermediate Similarity NPC232818
0.8343 Intermediate Similarity NPC195972
0.8333 Intermediate Similarity NPC148323
0.8333 Intermediate Similarity NPC189704
0.8333 Intermediate Similarity NPC283480
0.8324 Intermediate Similarity NPC224557
0.8324 Intermediate Similarity NPC292706
0.8314 Intermediate Similarity NPC99216
0.8314 Intermediate Similarity NPC469420
0.8305 Intermediate Similarity NPC83331
0.8305 Intermediate Similarity NPC470582
0.8305 Intermediate Similarity NPC470581
0.8305 Intermediate Similarity NPC115447
0.8304 Intermediate Similarity NPC473557
0.8304 Intermediate Similarity NPC471873
0.8304 Intermediate Similarity NPC473468
0.8304 Intermediate Similarity NPC475567
0.8303 Intermediate Similarity NPC327962
0.8295 Intermediate Similarity NPC70862
0.8294 Intermediate Similarity NPC269668
0.8293 Intermediate Similarity NPC325032
0.8293 Intermediate Similarity NPC477483
0.8284 Intermediate Similarity NPC257309
0.8284 Intermediate Similarity NPC208651
0.8284 Intermediate Similarity NPC29552
0.8284 Intermediate Similarity NPC206641
0.8282 Intermediate Similarity NPC208293
0.8278 Intermediate Similarity NPC229817
0.8278 Intermediate Similarity NPC96194
0.8278 Intermediate Similarity NPC221140
0.8278 Intermediate Similarity NPC475352
0.8278 Intermediate Similarity NPC241847
0.8278 Intermediate Similarity NPC475220
0.8278 Intermediate Similarity NPC299855
0.8278 Intermediate Similarity NPC473686
0.8274 Intermediate Similarity NPC82190
0.8274 Intermediate Similarity NPC174599
0.8274 Intermediate Similarity NPC192219
0.8274 Intermediate Similarity NPC477467
0.8263 Intermediate Similarity NPC474533
0.8263 Intermediate Similarity NPC474534
0.8258 Intermediate Similarity NPC195114
0.8253 Intermediate Similarity NPC69425
0.8253 Intermediate Similarity NPC77310
0.8251 Intermediate Similarity NPC473711
0.8249 Intermediate Similarity NPC289876
0.8246 Intermediate Similarity NPC293568
0.8246 Intermediate Similarity NPC266365
0.8246 Intermediate Similarity NPC471869
0.8246 Intermediate Similarity NPC117943
0.8229 Intermediate Similarity NPC43434
0.8229 Intermediate Similarity NPC478021
0.8229 Intermediate Similarity NPC472129
0.8226 Intermediate Similarity NPC131405
0.8225 Intermediate Similarity NPC477623
0.8218 Intermediate Similarity NPC63470
0.8214 Intermediate Similarity NPC477474
0.8214 Intermediate Similarity NPC477472
0.8214 Intermediate Similarity NPC472128
0.8214 Intermediate Similarity NPC205172
0.8214 Intermediate Similarity NPC209393
0.8214 Intermediate Similarity NPC477470
0.8214 Intermediate Similarity NPC472127
0.8214 Intermediate Similarity NPC474621
0.8214 Intermediate Similarity NPC469417
0.8214 Intermediate Similarity NPC474622
0.8212 Intermediate Similarity NPC477860
0.8212 Intermediate Similarity NPC475161
0.821 Intermediate Similarity NPC204644
0.8208 Intermediate Similarity NPC178281
0.8202 Intermediate Similarity NPC80360
0.8202 Intermediate Similarity NPC266513
0.8202 Intermediate Similarity NPC260300
0.8199 Intermediate Similarity NPC475513
0.8199 Intermediate Similarity NPC473755
0.8197 Intermediate Similarity NPC112708
0.8193 Intermediate Similarity NPC472548
0.8193 Intermediate Similarity NPC477905
0.8192 Intermediate Similarity NPC470583
0.8192 Intermediate Similarity NPC19056
0.8187 Intermediate Similarity NPC130489
0.8187 Intermediate Similarity NPC208676
0.8182 Intermediate Similarity NPC315619
0.8182 Intermediate Similarity NPC294501
0.8182 Intermediate Similarity NPC469448
0.8182 Intermediate Similarity NPC270027
0.8182 Intermediate Similarity NPC148185
0.8177 Intermediate Similarity NPC87583
0.8171 Intermediate Similarity NPC175477
0.8171 Intermediate Similarity NPC472133
0.8167 Intermediate Similarity NPC475662
0.8167 Intermediate Similarity NPC293227
0.8167 Intermediate Similarity NPC473717
0.8167 Intermediate Similarity NPC473205
0.8167 Intermediate Similarity NPC473776
0.8167 Intermediate Similarity NPC473631
0.8166 Intermediate Similarity NPC477736
0.8166 Intermediate Similarity NPC3449
0.8166 Intermediate Similarity NPC469399
0.8162 Intermediate Similarity NPC470200
0.8162 Intermediate Similarity NPC316274
0.8162 Intermediate Similarity NPC470196
0.8162 Intermediate Similarity NPC470193
0.8162 Intermediate Similarity NPC282474
0.8162 Intermediate Similarity NPC470198
0.8162 Intermediate Similarity NPC470195
0.8162 Intermediate Similarity NPC470194
0.8162 Intermediate Similarity NPC470197
0.8161 Intermediate Similarity NPC477488
0.816 Intermediate Similarity NPC25491
0.8156 Intermediate Similarity NPC58538
0.8155 Intermediate Similarity NPC471874
0.815 Intermediate Similarity NPC100420
0.8144 Intermediate Similarity NPC475407
0.8144 Intermediate Similarity NPC473966
0.8144 Intermediate Similarity NPC472657
0.8144 Intermediate Similarity NPC472658
0.8142 Intermediate Similarity NPC230670
0.8142 Intermediate Similarity NPC71385
0.814 Intermediate Similarity NPC198047
0.8136 Intermediate Similarity NPC203751
0.8136 Intermediate Similarity NPC168789
0.8133 Intermediate Similarity NPC329657
0.8133 Intermediate Similarity NPC279442
0.8132 Intermediate Similarity NPC282636
0.8132 Intermediate Similarity NPC294863

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC13989 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8563 High Similarity NPD8313 Approved
0.8563 High Similarity NPD8312 Approved
0.8132 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7947 Intermediate Similarity NPD8320 Phase 1
0.7947 Intermediate Similarity NPD8319 Approved
0.7826 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7814 Intermediate Similarity NPD8150 Discontinued
0.7809 Intermediate Similarity NPD7228 Approved
0.7791 Intermediate Similarity NPD8455 Phase 2
0.7765 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7735 Intermediate Similarity NPD6559 Discontinued
0.7725 Intermediate Similarity NPD7700 Phase 2
0.7725 Intermediate Similarity NPD7699 Phase 2
0.7722 Intermediate Similarity NPD7074 Phase 3
0.7692 Intermediate Similarity NPD8151 Discontinued
0.7661 Intermediate Similarity NPD7458 Discontinued
0.7657 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD7472 Approved
0.7617 Intermediate Similarity NPD7435 Discontinued
0.7611 Intermediate Similarity NPD7799 Discontinued
0.7605 Intermediate Similarity NPD8166 Discontinued
0.7596 Intermediate Similarity NPD7808 Phase 3
0.7569 Intermediate Similarity NPD7054 Approved
0.7566 Intermediate Similarity NPD6535 Approved
0.7566 Intermediate Similarity NPD6534 Approved
0.7541 Intermediate Similarity NPD7251 Discontinued
0.7541 Intermediate Similarity NPD7240 Approved
0.7527 Intermediate Similarity NPD8434 Phase 2
0.7526 Intermediate Similarity NPD7696 Phase 3
0.7526 Intermediate Similarity NPD7697 Approved
0.7526 Intermediate Similarity NPD7698 Approved
0.7525 Intermediate Similarity NPD7783 Phase 2
0.7525 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD3818 Discontinued
0.7487 Intermediate Similarity NPD7870 Phase 2
0.7487 Intermediate Similarity NPD7871 Phase 2
0.7486 Intermediate Similarity NPD6797 Phase 2
0.7475 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7475 Intermediate Similarity NPD7874 Approved
0.7474 Intermediate Similarity NPD6823 Phase 2
0.7473 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD7701 Phase 2
0.7461 Intermediate Similarity NPD6781 Approved
0.7461 Intermediate Similarity NPD6777 Approved
0.7461 Intermediate Similarity NPD6776 Approved
0.7461 Intermediate Similarity NPD6779 Approved
0.7461 Intermediate Similarity NPD6780 Approved
0.7461 Intermediate Similarity NPD6778 Approved
0.7461 Intermediate Similarity NPD6782 Approved
0.7429 Intermediate Similarity NPD37 Approved
0.7425 Intermediate Similarity NPD7266 Discontinued
0.7421 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD6212 Phase 3
0.7421 Intermediate Similarity NPD6213 Phase 3
0.7416 Intermediate Similarity NPD6234 Discontinued
0.7414 Intermediate Similarity NPD4380 Phase 2
0.7401 Intermediate Similarity NPD4966 Approved
0.7401 Intermediate Similarity NPD4965 Approved
0.7401 Intermediate Similarity NPD4967 Phase 2
0.736 Intermediate Similarity NPD7075 Discontinued
0.7351 Intermediate Similarity NPD7685 Pre-registration
0.735 Intermediate Similarity NPD7801 Approved
0.7312 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD7768 Phase 2
0.7297 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD7819 Suspended
0.7283 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD7473 Discontinued
0.7247 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD6959 Discontinued
0.7238 Intermediate Similarity NPD8127 Discontinued
0.7234 Intermediate Similarity NPD8407 Phase 2
0.7213 Intermediate Similarity NPD6166 Phase 2
0.7213 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD6232 Discontinued
0.7195 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD7003 Approved
0.7193 Intermediate Similarity NPD4628 Phase 3
0.7191 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7166 Intermediate Similarity NPD8368 Discontinued
0.716 Intermediate Similarity NPD5405 Approved
0.716 Intermediate Similarity NPD5406 Approved
0.716 Intermediate Similarity NPD5408 Approved
0.716 Intermediate Similarity NPD5404 Approved
0.7152 Intermediate Similarity NPD3764 Approved
0.7151 Intermediate Similarity NPD5402 Approved
0.7126 Intermediate Similarity NPD2532 Approved
0.7126 Intermediate Similarity NPD2534 Approved
0.7126 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD2533 Approved
0.7097 Intermediate Similarity NPD5844 Phase 1
0.7093 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7088 Intermediate Similarity NPD5494 Approved
0.7086 Intermediate Similarity NPD6273 Approved
0.7085 Intermediate Similarity NPD7680 Approved
0.7079 Intermediate Similarity NPD7411 Suspended
0.7062 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD3226 Approved
0.7059 Intermediate Similarity NPD2935 Discontinued
0.7056 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD5403 Approved
0.7043 Intermediate Similarity NPD3751 Discontinued
0.7039 Intermediate Similarity NPD6801 Discontinued
0.7029 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD6599 Discontinued
0.7015 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD7236 Approved
0.7 Intermediate Similarity NPD5761 Phase 2
0.7 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD5760 Phase 2
0.6995 Remote Similarity NPD8360 Approved
0.6995 Remote Similarity NPD8361 Approved
0.699 Remote Similarity NPD7930 Approved
0.6978 Remote Similarity NPD3749 Approved
0.6971 Remote Similarity NPD7390 Discontinued
0.6964 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6957 Remote Similarity NPD7199 Phase 2
0.6944 Remote Similarity NPD1934 Approved
0.6941 Remote Similarity NPD7097 Phase 1
0.6935 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6932 Remote Similarity NPD5401 Approved
0.6919 Remote Similarity NPD3787 Discontinued
0.6919 Remote Similarity NPD2346 Discontinued
0.691 Remote Similarity NPD7239 Suspended
0.6907 Remote Similarity NPD8435 Approved
0.6897 Remote Similarity NPD3750 Approved
0.6887 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6879 Remote Similarity NPD970 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6869 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6869 Remote Similarity NPD8059 Phase 3
0.6868 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6857 Remote Similarity NPD6190 Approved
0.6854 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6848 Remote Similarity NPD1470 Approved
0.6848 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6831 Remote Similarity NPD3882 Suspended
0.6813 Remote Similarity NPD1465 Phase 2
0.6805 Remote Similarity NPD6663 Approved
0.6804 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6802 Remote Similarity NPD2799 Discontinued
0.6791 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6784 Remote Similarity NPD8485 Approved
0.6782 Remote Similarity NPD1549 Phase 2
0.678 Remote Similarity NPD6799 Approved
0.6776 Remote Similarity NPD3817 Phase 2
0.6766 Remote Similarity NPD5736 Approved
0.6763 Remote Similarity NPD1551 Phase 2
0.6762 Remote Similarity NPD8404 Phase 2
0.675 Remote Similarity NPD9493 Approved
0.6744 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6743 Remote Similarity NPD2800 Approved
0.6743 Remote Similarity NPD6674 Discontinued
0.6743 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6742 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6742 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6738 Remote Similarity NPD5711 Approved
0.6738 Remote Similarity NPD5710 Approved
0.6726 Remote Similarity NPD6832 Phase 2
0.6725 Remote Similarity NPD1933 Approved
0.6725 Remote Similarity NPD230 Phase 1
0.6724 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6724 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6722 Remote Similarity NPD1653 Approved
0.6721 Remote Similarity NPD2801 Approved
0.6707 Remote Similarity NPD2798 Approved
0.6707 Remote Similarity NPD1201 Approved
0.6705 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6705 Remote Similarity NPD1510 Phase 2
0.6667 Remote Similarity NPD7497 Discontinued
0.665 Remote Similarity NPD7584 Approved
0.6648 Remote Similarity NPD7028 Phase 2
0.6648 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6647 Remote Similarity NPD2313 Discontinued
0.6628 Remote Similarity NPD447 Suspended
0.6628 Remote Similarity NPD6355 Discontinued
0.6626 Remote Similarity NPD8516 Approved
0.6626 Remote Similarity NPD8517 Approved
0.6626 Remote Similarity NPD8515 Approved
0.6617 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6615 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6609 Remote Similarity NPD3748 Approved
0.6607 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6602 Remote Similarity NPD7999 Approved
0.659 Remote Similarity NPD6651 Approved
0.659 Remote Similarity NPD1607 Approved
0.6588 Remote Similarity NPD7008 Discontinued
0.6585 Remote Similarity NPD5125 Phase 3
0.6585 Remote Similarity NPD5126 Approved
0.6571 Remote Similarity NPD6099 Approved
0.6571 Remote Similarity NPD6100 Approved
0.6571 Remote Similarity NPD2796 Approved
0.657 Remote Similarity NPD1240 Approved
0.6564 Remote Similarity NPD9545 Approved
0.6559 Remote Similarity NPD7058 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data